Literature DB >> 11849216

Severe decrease in peripheral blood dendritic cells in hairy cell leukaemia.

Anne Bourguin-Plonquet1, Hélène Rouard, Françoise Roudot-Thoraval, Coralie Bellanger, Jeanine Marquet, Marie-Hélène Delfau-Larue, Marine Diviné, Jean-Pierre Farcet.   

Abstract

Clinical studies in hairy cell leukaemia (HCL) have linked the frequent occurrence of infections due to intracellular pathogens and a profound monocytopenia. More recently, dendritic cells (DC), a subset of which are related to monocytes, were shown to be the professional antigen-presenting cells which stimulate the adaptive immune response. Using membrane markers and flow cytometry, we determined in peripheral blood whether various DC subsets and monocytes were impaired in HCL. Lymphoid and myeloid DC were virtually absent in five HCL patients with active disease. After treatment, both DC and monocytes recovered slowly. The decrease in DC suggests that defective antigen presentation could affect susceptibility to intracellular pathogens in HCL.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11849216     DOI: 10.1046/j.0007-1048.2001.03318.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  3 in total

1.  Impaired functionality and phenotypic profile of dendritic cells from patients with multiple myeloma.

Authors:  M K Brimnes; I M Svane; H E Johnsen
Journal:  Clin Exp Immunol       Date:  2006-04       Impact factor: 4.330

2.  Isolated Splenic Mycobacterial Disease: A Cause of Persistent Fever in a Hairy Cell Leukemia Patient.

Authors:  Vassilios Papadopoulos; Charalambos Kartsios; Anastassia Spyrou; Kostas Loukidis; Spyridon Miyakis; Stavroula Pervana; Charalambos Makridis; Anna Kioumi; Ioannis Korantzis
Journal:  Case Rep Gastroenterol       Date:  2010-09-11

3.  Coexistent hairy cell leukaemia and hepatosplenic T-cell lymphoma: a case report.

Authors:  Gorana Gasljevic; Veronika Kloboves-Prevodnik; Barbara Gazic; Marjeta Vovk
Journal:  Diagn Pathol       Date:  2014-03-12       Impact factor: 2.644

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.